Omid Tavana
6PUBLICATIONS
63CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 25, 2025
The Direction of Modern Therapies in Waldenström Macroglobulinaemia.Stephen Blackmore, Sherine Elsawa, Omid Tavana
|Sep 05, 2024
SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma.Ana Portelinha, Shenqiu Wang, Sara Parsa
|Mar 08, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.Azadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu
|Nov 09, 2021
Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets.Junjie Jiang, Jiao Yuan, Zhongyi Hu
|Sep 29, 2020
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.Srividya B Balachander, Steven W Criscione, Kate F Byth
|Aug 18, 2020
Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 Pseudokinase.Sébastien L Degorce, Omid Tavana, Erica Banks
Pageof 1
Frequent Collaborators
2 joint publications
Justin Cidado
2 joint publications
Mathew J Garnett
2 joint publications
Patricia Jaaks
2 joint publications
Elizabeth A Coker
1 joint publications
Sébastien L Degorce
1 joint publications
Kate F Byth
1 joint publications
Shenghua Wen
1 joint publications
Jeffrey W Tyner
1 joint publications
William McCoull
1 joint publications
Gareth P Gregory
